Abpro Holdings, Inc (ABP) Dividend History

Abpro Holdings, Inc. (ABP) is a biotechnology company focused on developing immuno-oncology and ophthalmology therapies. It specializes in creating innovative treatments using antibody-based approaches to address unmet medical needs in cancer and eye diseases. The company leverages its proprietary platform to discover and advance novel biologics.

Dividend History

Abpro Holdings, Inc currently does not pay dividends

Company News

Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager

Abpro and Celltrion presented preclinical data for their HER2 x CD3 T-cell engager ABP-102/CT-P72 at the AACR 2025 conference, suggesting potential for superior tumor selectivity, potent efficacy, and improved safety profile compared to existing HER2-targeted therapies.

GlobeNewswire Inc.

Page data last updated 08/18/2025 23:45:44 UTC